TMO
Thermo Fisher Scientific
Stock NYSE – Stock Market Prices, News & Analysis
Thermo Fisher Scientific Inc is a leading company in providing scientific solutions with products and services in the fields of laboratory, research, and clinical diagnostics.
Thermo Fisher Scientific
TMO
Thermo Fisher Scientific Inc is a leading company in providing scientific solutions with products and services in the fields of laboratory, research, and clinical diagnostics.
Price history of Thermo Fisher Scientific
Price history of Thermo Fisher Scientific
Performance & Momentum
Thermo Fisher Raises Dividend, Strengthens Data Partnerships
Thermo Fisher Scientific (Thermo Fisher Scientific Inc) announced a 10% increase in its quarterly dividend to $0.47 per share, reflecting confidence in its financial performance. Concurrently, the company formed a strategic partnership with Datavant to enhance the integration of real-world data in clinical research, bolstering its role in digital innovation within life sciences. Despite a slight decline in its stock price over the past year, Thermo Fisher outperforms peers in the medical devices sector, supported by a predominantly positive analyst consensus and strong anticipated growth in the preimplantation genetic testing market. These factors position the company favorably for medium-term growth.
Strategic Analysis
Thermo Fisher Scientific • 2026
Thermo Fisher Scientific positions itself as a global leader in advanced scientific solutions for laboratories, research, and clinical diagnostics. The company focuses on integrating cutting-edge technologies, including artificial intelligence, to enhance its offerings and improve operational efficiency in a rapidly evolving sector.
Strengths
- Dominant position in the market for scientific equipment and services with a large global base.
- Ability to forge strong strategic partnerships, particularly in the field of data and artificial intelligence.
- Attractive dividend distribution policy reflecting robust cash flow generation.
Weaknesses
- Recent stock performance has been mixed, with negative trends across several timeframes.
- Need for operational restructuring illustrated by factory closures, which may incur short-term costs.
Momentum
Current momentum is moderate with a valuation dynamic that is struggling to improve despite recent progress. The strategy of integrating AI and strengthening data partnerships does, however, bring positive momentum in the medium term, while operational adjustments demonstrate a willingness to optimize in the face of a demanding competitive environment.
Similar stocks to Thermo Fisher Scientific
Recent News
Thermo Fisher Scientific
Thermo Fisher's AI Deal and Plant Closure Shape Strategy
2 months agoThermo Fisher Scientific (TMO) is strengthening its position through a partnership with NVIDIA to integrate AI into its laboratory workflows, creating growth opportunities in life sciences. Simultaneously, the company plans to close its Asheville plant within two years, resulting in 421 job cuts, which may negatively impact short-term performance. Despite concerns over debt and currency fluctuations, analysts remain optimistic, raising the price target to $700.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
